Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Front-line”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00284752
What this trial is testing

Phase II Trial of Abraxane in Front Line Therapy of Hormone Refractory Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
Kaiser Permanente 56
Testing effectiveness (Phase 2)Looking for participantsNCT07734038
What this trial is testing

Venetoclax Plus Zanubrutinib for the Treatment of Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma

Who this might be right for
Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma
Kerry Rogers 155
Large-scale testing (Phase 3)Study completedNCT04504877
What this trial is testing

Burnout and Distress preventiOn With caNnabidiol in Front-line Health Care workerS deAling wIth COVID-19

Who this might be right for
Covid19Burn OutPost Traumatic Stress Disorder
University of Sao Paulo 120
Not applicableEnrolling By InvitationNCT05049668
What this trial is testing

RACE 2: a Long Term Follow-up of Patients Participating in the RACE Trial

Who this might be right for
Severe Aplastic Anemia
European Society for Blood and Marrow Transplantation 197
Testing effectiveness (Phase 2)Study completedNCT01263782
What this trial is testing

BATTLE-FL: Front-Line Biomarker-Integrated Treatment Study in Non Small Cell Lung Cancer

Who this might be right for
Lung Cancer
M.D. Anderson Cancer Center 64
Testing effectiveness (Phase 2)Ended earlyNCT03957551
What this trial is testing

Cabozantinib and Pembrolizumab for Advanced Metastatic Melanoma

Who this might be right for
Advanced Metastatic Melanoma
John Rieth 28
Testing effectiveness (Phase 2)Study completedNCT03023046
What this trial is testing

Etoposide, Prednisone, Vincristine Sulfate, Cyclophosphamide, and Doxorubicin in Treating Patients With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma

Who this might be right for
Acute Lymphoblastic LeukemiaLymphoblastic Lymphoma
University of Washington 54
Testing effectiveness (Phase 2)Study completedNCT05388123
What this trial is testing

Low Dose Vemurafenib and Rituximab in Hairy Cell Leukemia

Who this might be right for
Hairy Cell Leukemia
Scripps Health 15
Testing effectiveness (Phase 2)Study completedNCT02955823
What this trial is testing

A Phase II Study of the FIL on Elderly Frail Patients With DLBCL

Who this might be right for
Diffuse Large B-cells Non-Hodgkin Lymphoma
Fondazione Italiana Linfomi - ETS 68
Not applicableStudy completedNCT05831423
What this trial is testing

The Role of Licensing in Early Care and Education: Front-Line Licensing Staff

Who this might be right for
Licensing Staff Perceptions of the Licensing System
Child Trends 1,159
Early research (Phase 1)WithdrawnNCT02722135
What this trial is testing

Find a Safe Dose of Volasertib Given in Addition to Standard Salvage Chemotherapy in Children (Age 3 Months to Less Than 18 Years) With Acute Myeloid Leukaemia, in Whom Front-line Chemotherapy Failed

Who this might be right for
Leukemia, Myeloid, Acute
Boehringer Ingelheim
Testing effectiveness (Phase 2)Study completedNCT01075048
What this trial is testing

ARQ 197 in Combination With Chemotherapy in Patients With Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Daiichi Sankyo 131
Not applicableStudy completedNCT05498506
What this trial is testing

Multiple Firings in Double-stapled Colorectal Anastomosis

Who this might be right for
Rectal Cancer
Shanghai Minimally Invasive Surgery Center 350
Testing effectiveness (Phase 2)WithdrawnNCT00943553
What this trial is testing

Study of Epigenetic Priming Using Decitabine With Front Line Induction Chemotherapy Compared With Immediate Induction Chemotherapy in Pediatric Acute Myelogenous Leukemia (AML) Subjects

Who this might be right for
Acute Myelogenous Leukemia (AML)
Eisai Inc.
Testing effectiveness (Phase 2)Ended earlyNCT00086632
What this trial is testing

Study of Ovarex® (Oregovomab) MAb With Front-Line Chemotherapy for Ovarian Cancer Treatment

Who this might be right for
Ovarian Cancer
Unither Pharmaceuticals 40
Not applicableUnknownNCT06084923
What this trial is testing

Outcomes of Unfit Patients With CLL Included in the GIMEMA LLC1114 Trial Who Discontinued Ibrutinib Due to Reasons Other Than Disease Progression

Who this might be right for
Chronic Lymphocytic Leukemia
Gruppo Italiano Malattie EMatologiche dell'Adulto 73
Not applicableStudy completedNCT04933890
What this trial is testing

Detection of Heart Conditions Using Artificial Intelligence

Who this might be right for
Left Ventricular DysfunctionHeart Failure
Eko Devices, Inc. 68
Not applicableStudy completedNCT06004076
What this trial is testing

Fascial Release on Upper Cross Syndrome.

Who this might be right for
Upper Cross Syndrome
Cairo University 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT04722172
What this trial is testing

A Study on Limiting Treatment Time With Acalabrutinib Combined With Obinutuzumab in People With CLL or SLL

Who this might be right for
Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma
Memorial Sloan Kettering Cancer Center 55
Large-scale testing (Phase 3)Looking for participantsNCT05920356
What this trial is testing

A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)

Who this might be right for
Non-Small Cell Lung Cancer (NSCLC)
Amgen 750
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation